A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1)

NCT01245426 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: GW870086 2mg
DRUG: GW870086 4mg
DRUG: GW870086 Placebo
DRUG: GW870086 1mg
DRUG: GW870086 3mg

Sponsor

GlaxoSmithKline